Lucidome Bio appoints board chair
Lucidome Bio chief executive David Aitken said: 'We've built strong … foundations and are now focused on making technology breakthroughs, progressing regulatory pathways, and strengthening our commercial roadmap into the future. Bridgit has navigated this transition many times and understands how to balance bold thinking with tight execution. She is set to play a critical role in helping us move with clarity and intent.'
Hawkins brings deep experience in leading technology-driven companies from early concept phase through to scale and exit. As former founder and CEO of Regen Ltd, she is currently chief sustainability officer at farm management solution company CropX.
Hawkins' work has spanned startup governance, capital raising, intellectual property strategy, commercial partnerships, and measuring climate tech impact for global clients. With a master's degree in agricultural science, she has also completed executive training at Stanford University's Graduate School of Business and founded Fields of Change, an initiative focused on industry-wide solutions to systemic agricultural challenges.
'Early-stage governance is very different to conventional business-as-usual. You're dealing with high potential, limited resources, and a very fast-moving market. The skill is knowing where to focus – what truly matters – and how to use the resources you have to maximise their effect,' Hawkins explained.
Hawkins said what drew her to Lucidome Bio was a rare combination of breakthrough science, a purpose-led team, and a shared sense of urgency. 'The impact potential is enormous, the science is sound, and the belief is real. Now we need to show the world we can execute.'
The appointment comes as Lucidome Bio gains growing international recognition, following its selection as a 2025 global finalist at the Animal Health, Nutrition and Technology Innovation Showcase in Boston where the company's methane vaccine was recognised for its potential to transform livestock methane reduction at scale.
The technology targets methanogenic archaea – the microbes in a ruminant's gut responsible for methane production – by priming the animal's immune system to generate antibodies that reduce methanogen growth through a cost-effective vaccine. The result is a practical, science-backed solution that supports emission reductions without compromising animal health or productivity.
'In many parts of the world, feed additives or high-cost delivery systems simply aren't viable. A vaccine levels the playing field – it's scalable, cost-effective, and equitable and I look forward to ensuring Lucidome Bio gains traction both locally and on the global innovation stage,' concluded Hawkins.
This is supplied content and not commissioned or paid for by NBR.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
3 days ago
- Scoop
From Microbes To Markets: What It Takes To Deliver Methane Vaccines For Livestock
Methane vaccines are an attractive proposition because they build on natural immune responses, work with existing industry and farming practices, and are scalable globally. Their efficacy lies in stimulating an immune response that targets methanogens. By David Aitken, CEO, Lucidome Bio Reducing methane emissions from animal agriculture is no longer a hypothetical. At the 2025 State of the Science Summit: Reducing Methane from Animal Agriculture, held at UC Davis in California, one session in particular signalled how far we've come and how far we still need to go. The panel ' Advancements and Barriers Toward a Methane Reducing Vaccine ' brought together global leaders in immunology, agritech innovation, and biotech development to explore the scientific and regulatory frontiers of this emerging solution. Moderated by Professor Paul Wood, a member of the Scientific Oversight Committee of the Global Methane Hub and a recognised authority on livestock vaccines, the panel also featured: John Hammond, Principal Scientist, Pirbright Institute Colin South, CEO, ArkeaBio David Aitken, CEO, Lucidome Bio What followed was a rigorous, grounded discussion on where the science stands, what technical barriers remain, and how the sector can work collaboratively to move from early promise towards real-world impact. Why methane vaccines matter Enteric methane emissions from cattle, sheep, and other farmed ruminants are responsible for around 5% of total annual global greenhouse gas emissions based on Food and Agriculture Organization data. This is similar to the total annual greenhouse gas emissions of all the passenger cars around the world. Inger Andersen, Executive Director of the United Nations Environment Programme, has said that ' Cutting methane is the strongest lever we have to slow climate change over the next 25 years and complements necessary efforts to reduce carbon dioxide '. Methane vaccines are an attractive proposition because they build on natural immune responses, work with existing industry and farming practices, and are scalable globally. Their efficacy lies in stimulating an immune response that targets methanogens – specialised microbes in the rumen which are responsible for methane production – without disrupting digestion or affecting animal health. Scientific momentum – from antigen identification to animal trials Lucidome Bio is moving decisively from discovery to development. Our presentation at the summit outlined key milestones already achieved including: Screening over 2,000 relevant genes and filtering hundreds of vaccine targets for evaluation Prioritising a shortlist of 20+ vaccine candidates which are now going through in vitro testing and trials in cattle to assess immune response and effectiveness Demonstrating we can induce strong antibody responses and that these antibodies bind to methanogens We are using a range of tools from AI to bioinformatics to better understand how to trigger a strong, specific immune system response. Cattle trials are underway to measure how effectively the vaccine stimulates an immune response (immunogenicity) and effectiveness at reducing methane yields. These steps form part of a defined development pipeline that has been designed to de-risk each stage before moving toward commercial scale-up. Clarifying the barriers: perception, policy, and pace While scientific progress is tangible, the panel discussion made it clear that significant challenges remain. Attendees asked questions on several fronts: 1. Regulatory readiness Global regulators lack a common framework for methane vaccines for livestock as existing regulatory approval pathways have been developed for therapeutic vaccines. However, the panel noted that speed matters, that early adopter markets can accelerate regulatory approvals, and that there is an opportunity to meet core regulatory needs while building the larger scale deployment data that provides clarity to partners, investors, and governments. 2. Public and producer perception Pushback to new solutions is always a risk and can be rooted in a misunderstanding that these vaccines introduce something 'unnatural' to the animal. In reality, ruminant animals already recognise methanogens. Methane vaccines induce antibodies that may already be present at modest levels – effectively stimulating immune responses that are already part of the animal's biology. They aren't about inserting foreign organisms into food systems. This helps to support producer and consumer acceptance. 3. Collaboration vs competition A critical takeaway from the discussion is that collaboration is an important element to solving complicated vaccine challenges. Our team is already collaborating with a range of expert partners including AgResearch and Pirbright Institute to make the breakthroughs needed for a successful vaccine globally. No single technology can solve this challenge and the methane mitigation toolkit will need different options including a variety of feed additives, selective breeding, and lower methane pastures. These tools can complement one another and potentially be stacked to enhance the benefits – this isn't a winner-takes-all scenario. 4. Evolutionary response and efficacy What if the rumen microbiome evolves in a way that has other impacts on animals from inhibiting the growth of methanogens or makes a methane vaccine less effective over time? The panel acknowledged there is more work to do on this but that literature on methane reducing feed additives indicates that there should not be any negative impacts on productivity from a methane vaccine. We are targeting productivity gains from our vaccine but recognise a lot of work still needs to be done to achieve this as other sessions at the conference also explored. Methanogens share many similarities across ruminant species and countries which is helpful for efficacy and, just like flu vaccines can be updated for new strains, methane-reducing vaccines could also adapt as needed over time as research continues to progress. 5. Timeframes We often get asked when a methane vaccine will be ready. While this is influenced by how much investment we raise and the regulatory pathway in different countries, our focus is on demonstrating robust proof of concept in cattle and progress towards key elements of our first vaccine product over the next two years. We aim to get approved vaccines into the hands of farmers within five years. This aligns with a typical 3 – 5 year commercialisation timeframe post proof of concept that Professor Paul Wood highlighted during the discussion on other vaccines. The commercial approach is critical alongside technology development to delivering on this timeframe. There are opportunities to accelerate deployment through licensing opportunities with global animal health companies. Market impetus – supply chain momentum is here The commercial signals are encouraging. In New Zealand, where Lucidome Bio is based, dairy cooperative Fonterra – one of the world's largest – has committed to reducing supply chain emissions and will start offering financial incentives to farmers from 2025/26 who supply lower emissions milk. This mechanism is supported by Fonterra's customers Nestle and Mars showing how global agribusinesses can drive innovation through their supply chain. This type of leadership creates clear demand for tools such as methane vaccines. The future is within reach There is still a lot of work ahead – on technology development, public education, aligning regulatory pathways, and building multi-stakeholder coalitions – but the tone of the panel was clear: methane vaccines are no longer just about the fundamental science. They're now a credible, developing technology, generating a lot of interest across the sector. We've spent decades understanding this problem. It's time to invest just as deeply in solving it. Watch the event on catchup…
Scoop
11-06-2025
- Scoop
NZAGRC Changes Name To Ag Emissions Centre
Press Release – Ag Emissions Centre The new name is about being more visible, better connected, and more easily identified by the farmers, Mori agribusinesses, researchers, and industry partners we support. It reflects the Centres role as specialists in agricultural emissions, and the … The New Zealand Agricultural Greenhouse Gas Research Centre (NZAGRC) has a new name. It will now be known as the Ag Emissions Centre. Since 2009, the Ag Emissions Centre has led research to help farmers meet the growing challenge of agricultural greenhouse gas emissions. The new name will make it easier for farmers and industry to find and engage with the science, tools, and support that will help them reduce emissions. 'As international expectations around emissions have grown, so too has the pressure on farmers to respond, and our work has evolved alongside them,' says Dr Naomi Parker, Executive Director of the Ag Emissions Centre. 'The new name is about being more visible, better connected, and more easily identified by the farmers, Māori agribusinesses, researchers, and industry partners we support. It reflects the Centre's role as specialists in agricultural emissions, and the urgency of the challenge we're helping tackle.' While the name has changed, the Ag Emissions Centre's core mission remains the same: shaping and funding research that can help farmers, government, and industry meet global demands for low-emissions farming. Its research portfolio includes a methane vaccine and inhibitors, nitrous oxide inhibitors, low-methane livestock genetics, and farm systems research. Reducing agricultural emissions remains one of the most pressing issues facing New Zealand's primary sector. Agriculture makes up over 50% of the country's total emissions, and the pressure to demonstrate measurable reductions from global markets, customers, and trading partners is growing. 'Farmers are already feeling the effects of climate change and shifting market expectations,' says Dr Parker. 'Our role is to help discover and develop the tools and knowledge New Zealand farmers need to stay competitive, protect their markets, and keep farming sustainably into the future.' The Ag Emissions Centre will continue to operate as an independent unit within AgResearch, which will transition on 1 July 2025 to the new Bioeconomy Science Institute under the Government's wider science system reform. Existing contracts and relationships with research partners remain unchanged. Stakeholders will begin seeing the new name and branding, including new email addresses and website at from 1 July 2025.
Scoop
10-06-2025
- Scoop
Innovative Pasture Project To Drive Farmgate Returns
Minister of Agriculture The Government is backing a $17 million partnership with farmers to boost productivity, profitability, and sustainability by identifying the most resilient, high-performing pastures for New Zealand conditions, Agriculture Minister Todd McClay announced today at Fieldays. Minister McClay confirmed the Government will invest $8.269 million in the Resilient Pastures project through Budget 2025's new Primary Sector Growth Fund (PSGF), alongside sector leaders including DairyNZ, Beef + Lamb New Zealand, Fonterra, AgResearch, and others. 'This is a smart investment that will deliver real outcomes for farmers — increasing pasture performance, extending productive lifespan, cutting re-grassing costs, and improving profitability across the board,' McClay said. 'New Zealand farmers produce high-quality, safe, and sustainable food and fibre that is in demand around the world. Projects like this help us stay at the front of the pack —making it easier to farm productively and drive farm gate profitably.' The project will focus on the upper North Island, where pasture productivity has been challenging. Research and trials will develop region-specific pasture mixes and on-farm practices that respond to changing conditions, with farmers involved every step of the way. 'This is about innovation that delivers at the farmgate. By partnering with farmers and agri-leaders, we're backing practical solutions that drive growth and reduce red tape,' McClay says. Today's announcement builds on the Government's wider support for the sector, including: Over $400 million invested to accelerate emissions-reduction tools through AgriZeroNZ and NZAGRC; New technologies for nutrients, genetics, and pasture resilience already underway through PSGF; Ongoing work to remove outdated regulations and simplify compliance. 'Our message is clear: this Government backs farmers. We're here to grow value, not bureaucracy.'
